The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
- PMID: 30392731
- PMCID: PMC6251968
- DOI: 10.1016/S2215-0366(18)30337-7
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Erratum in
-
Correction to Lancet Psychiatry 2018; 5: 987-1012.Lancet Psychiatry. 2019 Jan;6(1):e2. doi: 10.1016/S2215-0366(18)30488-7. Lancet Psychiatry. 2019. PMID: 30579502 Free PMC article. No abstract available.
Abstract
Background: Alcohol and drug use can have negative consequences on the health, economy, productivity, and social aspects of communities. We aimed to use data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 to calculate global and regional estimates of the prevalence of alcohol, amphetamine, cannabis, cocaine, and opioid dependence, and to estimate global disease burden attributable to alcohol and drug use between 1990 and 2016, and for 195 countries and territories within 21 regions, and within seven super-regions. We also aimed to examine the association between disease burden and Socio-demographic Index (SDI) quintiles.
Methods: We searched PubMed, EMBASE, and PsycINFO databases for original epidemiological studies on alcohol and drug use published between Jan 1, 1980, and Sept 7, 2016, with out language restrictions, and used DisMod-MR 2.1, a Bayesian meta-regression tool, to estimate population-level prevalence of substance use disorders. We combined these estimates with disability weights to calculate years of life lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs) for 1990-2016. We also used a comparative assessment approach to estimate burden attributable to alcohol and drug use as risk factors for other health outcomes.
Findings: Globally, alcohol use disorders were the most prevalent of all substance use disorders, with 100·4 million estimated cases in 2016 (age-standardised prevalence 1320·8 cases per 100 000 people, 95% uncertainty interval [95% UI] 1181·2-1468·0). The most common drug use disorders were cannabis dependence (22·1 million cases; age-standardised prevalence 289·7 cases per 100 000 people, 95% UI 248·9-339·1) and opioid dependence (26·8 million cases; age-standardised prevalence 353·0 cases per 100 000 people, 309·9-405·9). Globally, in 2016, 99·2 million DALYs (95% UI 88·3-111·2) and 4·2% of all DALYs (3·7-4·6) were attributable to alcohol use, and 31·8 million DALYs (27·4-36·6) and 1·3% of all DALYs (1·2-1·5) were attributable to drug use as a risk factor. The burden of disease attributable to alcohol and drug use varied substantially across geographical locations, and much of this burden was due to the effect of substance use on other health outcomes. Contrasting patterns were observed for the association between total alcohol and drug-attributable burden and SDI: alcohol-attributable burden was highest in countries with a low SDI and middle-high middle SDI, whereas the burden due to drugs increased with higher S DI level.
Interpretation: Alcohol and drug use are important contributors to global disease burden. Effective interventions should be scaled up to prevent and reduce substance use disease burden.
Funding: Bill & Melinda Gates Foundation and Australian National Health and Medical Research Council.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures
Comment in
-
Mixed up: alcohol and society.Lancet Psychiatry. 2018 Dec;5(12):970. doi: 10.1016/S2215-0366(18)30432-2. Epub 2018 Nov 1. Lancet Psychiatry. 2018. PMID: 30392728 No abstract available.
-
New data to support much needed policy change.Lancet Psychiatry. 2018 Dec;5(12):947-948. doi: 10.1016/S2215-0366(18)30390-0. Epub 2018 Nov 1. Lancet Psychiatry. 2018. PMID: 30392730 No abstract available.
Similar articles
-
Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.Lancet Respir Med. 2017 Sep;5(9):691-706. doi: 10.1016/S2213-2600(17)30293-X. Epub 2017 Aug 16. Lancet Respir Med. 2017. PMID: 28822787 Free PMC article.
-
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6. Epub 2018 Nov 8. Lancet. 2018. PMID: 30496105 Free PMC article.
-
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.Lancet. 2013 Nov 9;382(9904):1564-74. doi: 10.1016/S0140-6736(13)61530-5. Epub 2013 Aug 29. Lancet. 2013. PMID: 23993281 Review.
-
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet. 2020 Oct 17;396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2. Lancet. 2020. PMID: 33069327 Free PMC article.
-
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10. Lancet Psychiatry. 2022. PMID: 35026139 Free PMC article.
Cited by
-
COVID-19 and addiction.Diabetes Metab Syndr. 2020 Sep-Oct;14(5):817-823. doi: 10.1016/j.dsx.2020.06.008. Epub 2020 Jun 9. Diabetes Metab Syndr. 2020. PMID: 32540735 Free PMC article. Review.
-
Alcohol-attributable mortality and alcohol control policy in the Baltic Countries and Poland in 2001-2020: an interrupted time-series analysis.Subst Abuse Treat Prev Policy. 2023 Nov 9;18(1):65. doi: 10.1186/s13011-023-00574-7. Subst Abuse Treat Prev Policy. 2023. PMID: 37946282 Free PMC article.
-
Alcohol Sensitivity as an Endophenotype of Alcohol Use Disorder: Exploring Its Translational Utility between Rodents and Humans.Brain Sci. 2020 Oct 13;10(10):725. doi: 10.3390/brainsci10100725. Brain Sci. 2020. PMID: 33066036 Free PMC article. Review.
-
Substance use and substance use disorders in Africa: An epidemiological approach to the review of existing literature.World J Psychiatry. 2022 Oct 19;12(10):1268-1286. doi: 10.5498/wjp.v12.i10.1268. eCollection 2022 Oct 19. World J Psychiatry. 2022. PMID: 36389088 Free PMC article. Review.
-
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110070. doi: 10.1016/j.pnpbp.2020.110070. Epub 2020 Aug 12. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32800868 Free PMC article. Review.
References
-
- Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379:55–70. - PubMed
-
- WHO . World Health Organization; Geneva: 1993. The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research.
-
- American Psychiatric Association . 4th edn. American Psychiatric Association; Washington DC: 2000. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR)
-
- Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39–49. - PubMed
